Possible role of RANKL in bone resorption
Udagawa, N.; Nakamura, M.; Takahashi, N.
Nihon Rinsho. Japanese Journal of Clinical Medicine 62(Suppl 2): 97-101
2004
ISSN/ISBN: 0047-1852 PMID: 15035104 Document Number: 569980
Document emailed within 1 workday
Related Documents
Mizoguchi, T. 2011: RANKL signaling and bone diseases. Quiescent osteoclast precursors and RANKL signaling Clinical Calcium 21(8): 1187-1192Xu, S.; Ma, X-Xi.; Hu, L-Wei.; Peng, L-Ping.; Pan, F-Ming.; Xu, J-Hua. 2014: Single nucleotide polymorphism of RANKL and OPG genes may play a role in bone and joint injury in rheumatoid arthritis Clinical and Experimental Rheumatology 32(5): 697-704
Miyaura, C. 2001: Role of EP4 receptor in bone resorption induced by PGE Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica 117(4): 293-297
Lerner, U.; Gustafson, G.T. 1980: A revised role for cyclic AMP in prostaglandin-induced bone resorption Medical Biology 58(1): 18-24
Chiang, C.-Y.; Fu, E.; Shen, E.-C. 2002: The role of interleukin-1beta in Porphyromonas gingivalis lipopolysaccharide-induced bone resorption Zhonghua Yi Xue Za Zhi 65(5): 225-230
Maldague, B.; Malghem, J. 1982: Intracortical bone resorption: its diagnostic value in metabolic bone diseases associated with high bone-turnover Annales de Radiologie 25(5): 333-336
Sajdak, S.; Krawczyk, J.; Piatek, J.; Kopczyński, Z. 2000: The applicability of biochemical markers of bone metabolism for predicting the risk of bone fractures and for the assessment of bone tissue resorption in the course of osteoporosis Clinical and Experimental Obstetrics and Gynecology 27(2): 118-120
Zhao, Y.; Cai, Y.; Wang, Y.-n. 2010: RANKL and OPG regulation on bone remodeling Shanghai Kou Qiang Yi Xue 19(4): 443-446
Juji, T.; Tanaka, S. 2004: Novel therapeutic approach to bone metabolic disorders using RANKL vaccination Nihon Rinsho. Japanese Journal of Clinical Medicine 62(Suppl 2): 799-802
Kreutzkamp, B. 2006: New mechanism of action RANKL-antibodies reduce bone loss Medizinische Monatsschrift für Pharmazeuten 29(11): 425-426
Yoneda, T. 2011: Involvement of RANKL/RANK pathway in bone metastasis in breast cancer Clinical Calcium 21(8): 1159-1166
Rude, R.K.; Kirchen, M.E.; Gruber, H.E.; Meyer, M.H.; Luck, J.S.; Crawford, D.L. 1999: Magnesium deficiency-induced osteoporosis in the rat: uncoupling of bone formation and bone resorption Magnesium Research 12(4): 257-267
Suda, T. 2002: How is bone formed and resorbed?-- molecular mechanisms of bone formation and resorption Rinsho Byori. Japanese Journal of Clinical Pathology 50(3): 267-272
Franke, S.; Lehmann, G.; Abendroth, K.; Hein, G.; Stein, G. 1998: PICP as bone formation and NTx as bone resorption marker in patients with chronic renal failure European Journal of Medical Research 3(1-2): 81-88
Yoneda, T. 2012: Treatment of bone metastasis by denosumab, the human monoclonal neutralizing antibody to RANKL Nihon Rinsho. Japanese Journal of Clinical Medicine 70(12): 2165-2171
Ciacli, C.; Puşchiţă, M. 2011: RANKL/RANK/OPG molecular complex--control factors in bone remodeling in psoriatic arthritis Revista Medico-Chirurgicala a Societatii de Medici Si Naturalisti Din Iasi 115(2): 354-360
Morimoto, Y. 1986: Metabolic bone diseases: various factors influencing bone resorption and osteogenesis--with special reference to the mechanism of action--steroid hormone Nihon Rinsho. Japanese Journal of Clinical Medicine 44(11): 2391-2398
Maiorana, C.; Redemagni, M.; Rabagliati, M.; Salina, S. 2000: Treatment of maxillary ridge resorption by sinus augmentation with iliac cancellous bone, anorganic bovine bone, and endosseous implants: a clinical and histologic report International Journal of Oral and Maxillofacial Implants 15(6): 873-878
Kaji, H. 2007: Parathyroid and bone. Effects of parathyroid hormone on bone resorption and formation: differences between intermittent and continuous treatment Clinical Calcium 17(12): 1836-1842
Kaneko, K.; Kawai, S. 2014: Glucocorticoid and Bone. Significance of serum soluble RANKL measurement in patients under glucocorticoid therapy Clinical Calcium 24(9): 1361-1370